基于单克隆抗体的白血病和淋巴瘤治疗方法。 - Suppr

Suppr

超能文献

Monoclonal antibody-based therapies of leukemia and lymphoma.

作者信息

Grossbard M L, Press O W, Appelbaum F R, Bernstein I D, Nadler L M

机构信息

Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, MA 02115.

出版信息

Blood. 1992 Aug 15;80(4):863-78.

PMID:1498329

Abstract

摘要

相似文献

Monoclonal antibody-based therapies of leukemia and lymphoma.

Blood. 1992 Aug 15;80(4):863-78.

Monoclonal antibodies in the study and therapy of hematopoietic cancers.

Curr Opin Immunol. 1992 Oct;4(5):641-6. doi: 10.1016/0952-7915(92)90040-l.

Current applications of monoclonal antibodies for the therapy of hematopoietic cancers.

Curr Opin Immunol. 1991 Oct;3(5):679-84. doi: 10.1016/0952-7915(91)90096-j.

Immunotoxin therapy of lymphoma.

Cancer Treat Res. 1993;68:111-31. doi: 10.1007/978-1-4615-3076-3_6.

Serotherapy of cancer.

Semin Oncol. 1989 Jun;16(3):180-98.

Monoclonal antibody therapy of leukemia and lymphoma.

Adv Pharmacol. 1995;33:287-314. doi: 10.1016/s1054-3589(08)60672-9.

Interleukin-2 receptor-directed therapies: antibody- or cytokine-based targeting molecules.

Adv Nephrol Necker Hosp. 1994;23:347-56.

Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma patients.

Haematologica. 1999 Jun;84 Suppl EHA-4:14-8.

Recent therapeutic advances in hematological malignancies: the role of targeted therapies in lymphoma.

Ann Oncol. 2008 Jul;19 Suppl 5:v63-7. doi: 10.1093/annonc/mdn313.

Advances in monoclonal antibody therapy of cancer.

Am J Med Sci. 1992 Sep;304(3):214-24. doi: 10.1097/00000441-199209000-00011.

引用本文的文献

Evaluating the immune effector functions induced by humanized anti-CD99 antibody in eliminating T lymphoblastic leukemia/lymphoma cells.

Discov Oncol. 2025 Apr 11;16(1):514. doi: 10.1007/s12672-025-02281-0.

Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16a/NKG2D Immune-Modulating TriNKET CC-96191.

Cancers (Basel). 2024 Feb 22;16(5):877. doi: 10.3390/cancers16050877.

Real-world data from yttrium-90 ibritumomab tiuxetan treatment of relapsed or refractory indolent B-cell non-Hodgkin's lymphoma: J3Zi Study.

Ann Hematol. 2023 May;102(5):1149-1158. doi: 10.1007/s00277-023-05157-x. Epub 2023 Mar 30.

Cutaneous Lymphoma and Antibody-Directed Therapies.

Antibodies (Basel). 2023 Mar 3;12(1):21. doi: 10.3390/antib12010021.

Where do we stand with radioimmunotherapy for acute myeloid leukemia?

Expert Opin Biol Ther. 2022 May;22(5):555-561. doi: 10.1080/14712598.2022.2060735. Epub 2022 Mar 31.

An Update on the Clinical Evaluation of Antibody-Based Therapeutics in Acute Myeloid Leukemia.

Curr Hematol Malig Rep. 2021 Feb;16(1):89-96. doi: 10.1007/s11899-021-00612-w. Epub 2021 Feb 25.

Therapeutic antibodies for mantle cell lymphoma: A brand-new era ahead.

Heliyon. 2019 Mar 7;5(3):e01297. doi: 10.1016/j.heliyon.2019.e01297. eCollection 2019 Mar.

From rabbit antibody repertoires to rabbit monoclonal antibodies.

Exp Mol Med. 2017 Mar 24;49(3):e305. doi: 10.1038/emm.2017.23.

90 Y-ibritumomab tiuxetan: a nearly forgotten opportunityr.

Oncotarget. 2016 Feb 16;7(7):7597-609. doi: 10.18632/oncotarget.6531.

Radioimmunotherapy in mantle cell lymphoma.

Best Pract Res Clin Haematol. 2012 Jun;25(2):201-10. doi: 10.1016/j.beha.2012.04.004. Epub 2012 May 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Monoclonal antibody-based therapies of leukemia and lymphoma.

Blood. 1992 Aug 15;80(4):863-78.

Monoclonal antibodies in the study and therapy of hematopoietic cancers.

Curr Opin Immunol. 1992 Oct;4(5):641-6. doi: 10.1016/0952-7915(92)90040-l.

Current applications of monoclonal antibodies for the therapy of hematopoietic cancers.

Curr Opin Immunol. 1991 Oct;3(5):679-84. doi: 10.1016/0952-7915(91)90096-j.

Immunotoxin therapy of lymphoma.

Cancer Treat Res. 1993;68:111-31. doi: 10.1007/978-1-4615-3076-3_6.

Serotherapy of cancer.

Semin Oncol. 1989 Jun;16(3):180-98.

Monoclonal antibody therapy of leukemia and lymphoma.

Adv Pharmacol. 1995;33:287-314. doi: 10.1016/s1054-3589(08)60672-9.

Interleukin-2 receptor-directed therapies: antibody- or cytokine-based targeting molecules.

Adv Nephrol Necker Hosp. 1994;23:347-56.

Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma patients.

Haematologica. 1999 Jun;84 Suppl EHA-4:14-8.

Recent therapeutic advances in hematological malignancies: the role of targeted therapies in lymphoma.

Ann Oncol. 2008 Jul;19 Suppl 5:v63-7. doi: 10.1093/annonc/mdn313.

Advances in monoclonal antibody therapy of cancer.

Am J Med Sci. 1992 Sep;304(3):214-24. doi: 10.1097/00000441-199209000-00011.

引用本文的文献

Evaluating the immune effector functions induced by humanized anti-CD99 antibody in eliminating T lymphoblastic leukemia/lymphoma cells.

Discov Oncol. 2025 Apr 11;16(1):514. doi: 10.1007/s12672-025-02281-0.

Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16a/NKG2D Immune-Modulating TriNKET CC-96191.

Cancers (Basel). 2024 Feb 22;16(5):877. doi: 10.3390/cancers16050877.

Real-world data from yttrium-90 ibritumomab tiuxetan treatment of relapsed or refractory indolent B-cell non-Hodgkin's lymphoma: J3Zi Study.

Ann Hematol. 2023 May;102(5):1149-1158. doi: 10.1007/s00277-023-05157-x. Epub 2023 Mar 30.

Cutaneous Lymphoma and Antibody-Directed Therapies.

Antibodies (Basel). 2023 Mar 3;12(1):21. doi: 10.3390/antib12010021.

Where do we stand with radioimmunotherapy for acute myeloid leukemia?

Expert Opin Biol Ther. 2022 May;22(5):555-561. doi: 10.1080/14712598.2022.2060735. Epub 2022 Mar 31.

An Update on the Clinical Evaluation of Antibody-Based Therapeutics in Acute Myeloid Leukemia.

Curr Hematol Malig Rep. 2021 Feb;16(1):89-96. doi: 10.1007/s11899-021-00612-w. Epub 2021 Feb 25.

Therapeutic antibodies for mantle cell lymphoma: A brand-new era ahead.

Heliyon. 2019 Mar 7;5(3):e01297. doi: 10.1016/j.heliyon.2019.e01297. eCollection 2019 Mar.

From rabbit antibody repertoires to rabbit monoclonal antibodies.

Exp Mol Med. 2017 Mar 24;49(3):e305. doi: 10.1038/emm.2017.23.

90 Y-ibritumomab tiuxetan: a nearly forgotten opportunityr.

Oncotarget. 2016 Feb 16;7(7):7597-609. doi: 10.18632/oncotarget.6531.

Radioimmunotherapy in mantle cell lymphoma.

Best Pract Res Clin Haematol. 2012 Jun;25(2):201-10. doi: 10.1016/j.beha.2012.04.004. Epub 2012 May 9.